Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase

Molecular Biology Reports

Volumn 38, Issue 1, 2011, Pages 553-559

  Shen, Li Li ^a   Liu, Hong ^a   Peng, Jiahe ^a   Gan, Lin ^a   Lu, Li ^a   Zhang, Qian ^a   Li, Liangpeng ^a   He, Fengtian ^a   Jiang, Yu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Bile acid; Fatty acid synthetase; Hepatic lipase; The farnesoid X receptor; Triglyceride

Indexed keywords

CHENODEOXYCHOLIC ACID; FARNESOID X RECEPTOR; FATTY ACID SYNTHASE; LIVER TRIACYLGLYCEROL LIPASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HOMEOSTASIS; HUMAN; HUMAN CELL; LOW DRUG DOSE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CHENODEOXYCHOLIC ACID; CHOLESTEROL; DOWN-REGULATION; FATTY ACID SYNTHETASE COMPLEX; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIPASE; LIVER; MICE; MICE, INBRED C57BL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC;

MUS;

EID: 78651081729     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0140-0     Document Type: Article

References (26)

1. T Nakamura K Kugiyama 2006 Triglycerides and remnant particles as risk factors for coronary artery disease Curr Atheroscler Rep 8 2 107 110 1:CAS:528:DC%2BD28XivVKltLs%3D 10.1007/s11883-006-0047-3 16510044
2. HN Ginsberg 2001 Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy Am J Cardiol 87 1174 1180 1:CAS:528:DC%2BD3MXjsFehtbw%3D 10.1016/S0002-9149(01)01489-8 11356393 (Pubitemid 32453238)
3. A Jayakumar MH Tai NY Huang, et al. 1995 Human fatty acid synthase properties and molecular cloning Proc Natl Acad Sci USA 1292 19 86 95
4. B Oskouian 2000 Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism Cancer Lett 149 43 51 1:CAS:528:DC%2BD3cXht1Ojt7o%3D 10.1016/S0304-3835(99)00342-0 10737707 (Pubitemid 30100559)
5. SS Wolf G Hofer KF Beck K Roder M Schweizer 1994 Insulin-responsive regions of the rat fatty acid synthase gene promoter Biochem Biophys Res Commun 203 943 950 1:CAS:528:DyaK2cXlvFOnsbg%3D 10.1006/bbrc.1994.2273 8093078 (Pubitemid 24304920)
6. S Ishii K Iizuka BC Miller K Uyeda 2004 Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription Proc Natl Acad Sci USA 101 15597 15602 1:CAS:528:DC%2BD2cXhtVWisLrN 10.1073/pnas. 0405238101 15496471 (Pubitemid 39473533)
7. S Xiong SS Chirala MH Hsu SJ Wakil 1998 Identification of thyroid hormone response elements in the human fatty acid synthase promoter Proc Natl Acad Sci USA 95 12260 12265 1:CAS:528:DyaK1cXmsl2rsLc%3D 10.1073/pnas.95.21.12260 9770474 (Pubitemid 28483753)
8. MK Bennett JM Lopez HB Sanchez TF Osborne 1995 Sterol regulation of fatty acid synthase promoter J Biol Chem 270 25578 25583 1:CAS:528:DyaK2MXovFylurk%3D 10.1074/jbc.270.43.25578 7592729
9. HR Kast CM Nguyen CJ Signal, et al. 2001 Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids Mol Endocrinol 15 10 1720 1728 1:CAS:528:DC%2BD3MXnt12isbw%3D 10.1210/me.15.10.1720 11579204 (Pubitemid 32939302)
10. AM Anisfeld HR Kast-Woelbem ME Meyer, et al. 2003 Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor J Biol Chem 278 22 20420 20428 1:CAS:528:DC%2BD3sXktVejsLY%3D 10.1074/jbc.M302505200 12660231 (Pubitemid 36799244)
11. S Bilz V Samuel K Morino, et al. 2006 Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters Am J Physiol Endocrinol Metab 290 4 716 722 10.1152/ajpendo.00355.2005
12. GL Guo Silvia Santamarina-Fojo TE Akiyama, et al. 2006 Effects of FXR in foam-cell formation and atherosclerosis development Biochim Biophys Acta 1761 1401 1409 1:CAS:528:DC%2BD28Xht1Knsr%2FN 17110163
13. A Sirvent T Claudel G Martin, et al. 2004 The farnesoid X receptor induces very low density lipoprotein receptor gene expression FEBS Lett 566 173 177 1:CAS:528:DC%2BD2cXktVOks70%3D 10.1016/j.febslet.2004.04.026 15147890 (Pubitemid 38625954)
14. S Shibata K Hayakawa Y Eqashira, et al. 2007 Roles of nuclear receptors in the up-regulation of hepatic cholesterol 7alpha-hydroxylase by cholestyramine in rats Life Sci 80 6 546 553 1:CAS:528:DC%2BD2sXisVOjtQ%3D%3D 10.1016/j.lfs.2006.10.003 17107691 (Pubitemid 46038327)
15. Ni HX, Yu NJ, Yang XH (2009) The study of ginsenoside on PPARgamma expression of mononuclear macrophage in type 2 diabetes. Mol Biol Rep. Oct 10 [Epub ahead of print]
16. Y John L Chiang 2004 Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms J Hepatol 40 539 551 10.1016/j.jhep.2003.11.006 (Pubitemid 38230860)
17. Y Naoya S Hitoshi H Kiyoshi, et al. 2005 Coordinate activation of lipogenic enzymes in hepatocellular carcinoma Kenichi Eur J Cancer 41 1316 1322 10.1016/j.ejca.2004.12.037 (Pubitemid 40813009)
18. A Sirvent AM Verhoeven H Jansen, et al. 2004 Farnesoid X receptor represses hepatic lipase gene expression J Lipid Res 459 2 2110 2115 10.1194/jlr.M400221-JLR200 (Pubitemid 40990906)
19. WW Zeng B Zhou HR Liu GT Sun BS Chen 2009 Identification of the tree shrew ATP-binding cassette transporter A1 (ABCA1) and its expression in tissues: cDNA sequence and expression of tree shrew ABCA1 Mol Biol Rep 36 3 443 448 1:CAS:528:DC%2BD1MXhvF2lur0%3D 10.1007/s11033-007-9199-7 18080840
20. Zhao YP, Zhang CM, Zhu C, Chen XH, Wang JL, Ji CB, Chi X, Hong Q, Peng YZ, Guo XR (2009) NYGGF4 homologous gene expression in 3T3-L1 adipocytes: regulation by FFA and adipokines. Mol Biol Rep. Nov 6 [Epub ahead of print]
21. KA Dugi JM Amar CC Haudenschild, et al. 2000 In Vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL Arterioscler Thromb Vasc Biol 20 3 793 800 1:CAS:528:DC%2BD3cXit1aksro%3D 10712405
22. KE Matsukuma MK Bennett J Huang, et al. 2006 Coordinated control of bile acids and lipogenesis through FXR dependent regulation of fatty acid synthase J Lipid Res 47 12 2754 2773 1:CAS:528:DC%2BD28XhtlSitL7M 10.1194/jlr.M600342- JLR200 16957179 (Pubitemid 44936088)
23. B Angelin K Einarsson K Hellstrom B Leijd 1978 Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia J Lipid Res 19 1017 1024 1:STN:280:DyaE1M%2FovFyrtQ%3D%3D 731123 (Pubitemid 9059813)
24. MC Bateson D Maclean JR Evans IA Bouchier 1978 Chenodeoxycholic acid therapy for hypertriglyceridaemia in men Br J Clin Pharmacol 5 249 254 1:STN:280:DyaE1c7oslShuw%3D%3D 656270
25. M Watanabe SM Houten L Wang A Moschetta DJ Mangelsdorf RA Heyman DD Moore J Auwerx 2004 Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J Clin Invest 113 1408 1418 1:CAS:528:DC%2BD2cXktlCltro%3D 15146238
26. H Dichek S Johnson H Akeefe, et al. 2001 Hepatic lipase over expression lowers remnant and LDL receptor-deficient mice J Lipid Res 42 2 201 210 1:CAS:528:DC%2BD3MXhs1Krt7g%3D 11181749